
Ophthalmic Medical Device R&D Developer




Recently, Robotrak Technologies ushered in dual good news with its independently developedRanklight® Intelligent Retinal Navigation Laser Receives Class III Medical Device Registration Certificate from China's National Medical Products Administration, while the companyAwarded as the "Outstanding Unit in the AI Medical Device Innovation Task by the MIIT and NMPA"Its "Ophthalmic All-Solid-State Laser Photocoagulator" (also known as: ZhiGuang® Intelligent Retinal Navigation Laser)Successfully Selected as "Intelligent Auxiliary Treatment Product", Project No.: 2024-AIFZZL-02015.




The ChiGuang® Intelligent Fundus Navigation Laser not only addresses multiple pain points of traditional slit-lamp laser treatment but also offers significant advantages such as intelligence, speed, and precision. With the integration of 5G technology, this device can also enable remote laser treatment, facilitating the further penetration of fundus laser photocoagulation technology and improving the accessibility of high-quality medical resources in China, benefiting tens of millions of patients with fundus diseases.
Since 2021, the Ministry of Industry and Information Technology and the National Medical Products Administration have jointly launched the AI Medical Device Innovation Task Public Challenge. A total of 1,035 projects were submitted across China. After multiple rounds of selection, 221 teams (72 on the main list and 149 with potential) with strong foundations, high clinical value, and advanced technical capabilities entered the final stage. Following two years of in-depth research and development, 104 organizations (67 key industry enterprises and 37 authoritative medical institutions) stood out and were awarded the title of "Outstanding Unit in the AI Medical Device Innovation Task Public Challenge."
From application to announcement, and then to obtaining the registration certificate, every step embodies the hard work of Robotrak Technologies' team and their relentless pursuit of excellence. We are committed to integrating the most cutting-edge technology into the medical field, continuously breaking the boundaries of traditional treatment, and making a clearer world accessible for everyone!

100+ Portfolio Ecosystem
Innovative Pharmaceuticals/Biotechnology

Purinomia
ITabMed
Shandun Pharmaceuticals
Xunji Bio
Larkspur
Ansun
Enrui Ni


Cytek
Gewu Zhihe
Genotix

CareHealth
Liget

Aiborn Technologies
RuiMu Biotech
Zhengli Technology

Biocytogen
Sincerity CRO
Opmay
Pharmacodia
Jingyu Group

Quadriga
Dr. Zhaoyang
Cognition
Lysoway
Regenacy

Sentieon
Geneis Orient
Profusa

Twist
VentureLab

Nabio Biotech
Wangdu Biotech
Qingyuan Nongguan
Oubofang

Follow 「Herbal Capital"】WeChat Official Account and set it as 'Star ⭐' to get the latest updates第一时间收获最新推送"

